Using Complexity and Spectral Analyses of Noninvasive LDF Signals in Patients with Metabolic Syndrome

Table 3

Fundamental physiological parameters (quantity or mean ± standard deviation) of subjects.

Parameters	MetS	Pre-MetS	Control	Statistical significance
	()	()	()
Gender (male/female)	27/14	22/45	15/19
Age (years)	44.5 ± 10.6	48.4 ± 12.9	42.7 ± 10.5
Heart rate (beats/minute)	73.3 ± 9.2	73.3 ± 9.5	71.1 ± 8.2
BMI (kg/m^2)	26.8 ± 3.5	24.4 ± 3.8	22.3 ± 3.0	AC
Waist circumference (cm)	89.3 ± 8.2	82.9 ± 8.9	79.6 ± 9.1	AC
Systolic blood pressure (mm-Hg)	126.2 ± 12.5	119.8 ± 14.5	106.1 ± 11.3	AC, BC
Diastolic blood pressure (mm-Hg)	85.7 ± 7.5	79.5 ± 10.4	70.4 ± 6.9	AC, BC
HDL-C (mg/dl)	39.8 ± 10.0	57.1 ± 9.5	60.3 ± 13.7	AB, AC
Fasting glucose (mg/dl)	98.4 ± 8.8	90.3 ± 6.5	85.1 ± 5.1	AB, AC
Triglyceride (mg/dl)	237.6 ± 168.1	101.0 ± 42.2	93.2 ± 32.4	AB, AC

Significant difference between groups (). A: MetS, B: pre-MetS, and C: control.